Bristol Foresees Earnings Growth In 2007 After Patent Expirations Subside
This article was originally published in The Pink Sheet Daily
Executive Summary
Sales from marketed and pipeline products will "more or less" offset expected exclusivity losses, but changes in product mix will negatively impact gross margins. Bristol increases 2004 non-GAAP earnings-per-share guidance by 10¢.